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Cryotherapy of Liver Tumour
Practical Guide
W. B. ROSS, M. HORTON, P. BERTOLINO and D. L. MORRIS 1,*
lUniversity ofNew South Wales, Department of Surgery and 2Anaesthetic Department The St. George Hospital
The use of cryotherapy for the treatment of some unresectable liver tumours has been clearly
established as a therapeutic option. Intra-operative ultrasound has enhanced the process by enabling
the surgeon to identify hepatic lesions and to allow visualisation ofthe freezing process to ensure that
the cryolesion will include thetumourmass. The purpose ofthis paper is to provide a practical guide to
surgeons who wish to perform cryotherapy of liver tumours. Patient selection and anaesthetic
considerations are important. The surgeon should be able to deal with the complications of
cryotherapy, particularly the intra-operative haemorrhage which may arise from cracking ofthe
hepatic parenchyma as the iceball thaws. Follow-up is based on tumourmarker assay and imaging of
the liver and repeat cryotherapy can be considered for selected cases.
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INTRODUCTION
The destruction of tumours by freezing is not new and
much experimental work has been done using liquid nitro-
gen systems, on which current machines are based 1-3.
However, there have been considerable recent advances
in the equipment used for hepatic cryotherapy, the control
offreezing by intra-operative ultrasound monitoring and
advances in techniques for accurate probe placement4,5.
This procedure has largely been associated with little
morbidity. The first large report of hepatic cryosurgery
was in hepatocellular cancer6. There is now considerable
evidence of reduction of serum CEA concentrations in
patients with metastases from colorectal cancerv,8 after
cryotherapy and there are encouraging survival results 9,10,
with some patients in complete remission9. Hepatic
cryotherapy has in our experience been a very safe proce-
dure but we believe that this is at least partly due to the
protocols ofperi-operative care which have been formu-
lated as result ofour early experience and that ofothers1.
*Addressfor correspondence." Professor D. L. Morris
University of New South Wales, Department of Surgery
The St. George Hospital Kogarah, SydneyNSW 2217 Australia
This paper is entirely dedicated to "How to do hepatic
cryosurgery".
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METHOD
Patient Select&n
The majority ofpatients treated with hepatic cryotherapy
in our unit have multiple colorectal cancer metastases. A
smaller number ofhepatomas, neuroendocrine tumours
and miscellaneous tumours have also been treated.
Surgical resection remains our treatment ofchoice but, if
the tumours are considered unresectable or the patient a
poor risk for liver resection, then cryotherapy may be
appropriate. Colorectal cancer metastases are considered
unresectable if:- there are more than three hepatic
metastases, both right and left lobes are involved, a cm
margin of clearance cannot be achieved (e.g. single
deposits close to vital structures). The presence ofextra-
hepatic malignancy is also considered a contra-indication
for cryotherapy but portal lymph nodes within the
perfusion territory ofour regional perfusion cathetermay
be an exception.We have considered that tumours with a
diameter greater than 6cm are unsuitable for cryotherapy,
although the use ofconcurrent multiple probesmay allow168 W.B. ROSS et al.
their treatment. Themaximum number ofhepatic deposits
we have treated in one patient is 15. Patients with more
than 15 hepatic deposits are offered alternative treatment
where appropriate, including repeated regional perfusion
with cytotoxics and selective artery chemoembolization.
We have had limited experience with other tumours but
melanoma in particularmay not be as suitable because of
the friability oftumour tissue (the single patientwe treated
required packing to control haemorrhtge from multiple
cracks in the iceball). Hepatocellular carcinoma was the
first indication for hepatic cryotherapy and can be used if
the tumour is not resectable6. It is certainly attractive in
cirrhotic patients, where resection of functioning liver is
avoided. Cirrhosis invariably, however, will increase the
risks ofcryotherapy. We have only treated two cirrhotics
to date. Neuroendocrine tumours have been treated, even
when there is extra-hepatic disease. Cardiovascular and
respiratory function of the patients should be able to
tolerate a prolonged anaesthetic (up to eight hours) and
the possibility of intra-operative haemorrhage from
treated lesions but we have treatedmany old patients with
pre-existing cardiac and respiratory disease and patients
ofreligious sects where blood transfusion is not accepted.
We have not treated patients, who are jaundiced due to
their liver tumour, by cryotherapy.
The majority of patients can be classified into
categoriesASA or 11. Pugh’s or Child’s classification for
determining surgical risk is not useful in these patients.
Table 2 Standard anaesthetic moni-
toring for hepatic cryotherapy
ECG F10
SaO2 Nerve Stimulator
ET CO2 Urinary Catheter
Pre-OperativeInvestigations
Patients are seen pre-operatively and routine investiga-
tions ordered. Tumourmarker assay is also ordered where
appropriate, e.g. carcinoembryonic antigen (CEA) or
alphafeto protein (AFP). Before surgery, all CT scans are
reviewed with the same radiologist to re-evaluate the
disease present and to plan treatment. Bowel preparation
is routine, with four litres of electrolyte-polyethylene
glycol solution. If a liver resection is considered to be an
intra-operative option as an alternative or adjunct, then
one litre of 10% dextrose is given intravenously pre-
operatively. All patients (except those undergoing liver
resection) receive 5,000 units ofsubcutaneous heparin as
prophylaxis against venous thrombosis. In addition,
sequential calfcompression is used during the operation.
Broad spectrum prophylactic antibiotics are given intra-
venously at the time ofanaesthetic induction (Cefotaxime
g IV). As we routinely insert a hepatic artery access port,
it is important that antibiotic prophylaxis covers staphylo-
coccus. If concomitant colonic resection is planned,
patients also receive intravenous metronidazole.
Investigations
Pre-operative investigations (Table 1) are done to confirm
normal or near normal physiological and biochemical
function and as baseline measurements to monitor
development ofintra-and post-operative complications.
Two additional pre-operative arrangements need to be
made, one with the Blood Bank to ensure a ready supply of
compatible blood, procoagulants and platelets ifrequired
and, second, with the High Dependency or Intensive Care
Unit to monitor progress and recovery of these patients
for the first 48 hours.
Table Pre-operative investigations for patients
undergoing hepatic cryotherapy
Electrolytes Creatinine Urea
Liver Function Tests Albumin
Clotting profile
Full blood count
Blood glucose level
Bone scan
Chest x-ray
ECG
EquipmentandPersonnel
We have used the L.C.S. System (Cryogenic Technology
Ltd, Belper, UK) for all our cryotherapywork in Australia
(Figure 1). This is a large capacity system designed
specifically for hepatic cryotherapy to deliver liquid
nitrogen to the tip of a triple lumen probe applied to the
lesion to be frozen. Large ice-balls form in the tissue
surrounding the probe. The shaft ofthe probe is insulated,
allowing precise destruction of deeply placed hepatic
lesions without significant thermal damage to overlying
liver tissue.We use three probes at present: 5mm and 9mm
insulated trocar probes and a flat plate probe (Figure 2).
The current machine allows simultaneous use of two
probes, although four-line machines are now available and
would be an advantage for hepatic work and essential if
prostatic cryotherapy is also to be done. A unique thaw
system has been incorporated in the specially-engineered
probe to allow quicker probe detachment after freezing.
Heated nitrogen gas is used in the thawing process. Liquid
nitrogen (30 liters) is stored in a double walled vacuum
insulated storage vessel (Dewar) with the system. This is
filled from a storage tank on site under pressure before theCRYOTHERAPYOF LIVERTUMOURS 169
Figure Cryotech LC2000 cryotherapy apparatus.
cryotherapy procedure. The Dewar pressure is
maintained at40 p.s.i, during cryotherapy but pressuresup
to 55 p.s.i, can be used. Lowering the pressure to a
minimum of 25 p.s.i, is a method of preserving liquid
nitrogen during a long freeze for a large lesion but we
believe that flow rate is probably of importance in
achieving ice balls ofadequate size for large livers.We use
three types ofprobes (Figure 2). The first flat probe can be
applied to surface lesions, while the two long trocar-tipped
probes are inserted into the centre of lesions. The larger
probe (9 cm) results in faster freezing but clearly leaves a
larger defect on extraction than the smaller probe (5 mm).
We now very seldom use the flat plate probe because of
the limited depth ofice ball that it achieves, although it can
Figure 2 Cryoprobes: Left 5mm trochar-tipped probe, middle
9 mm trochar-tipped probe, right-plate.
be suitable for ovarian tumour where relatively thin
plaques oftumour can be seen or treating an inadequate
margin ofliver resection. The freeze cycle should start at a
Dewar pressure of40 p.s.i.. This pressure is maintained for
at least five minutes before it can be reduced if a long
freeze cycle is anticipated. Exhaust gas is vented through a
tube from the proximal part ofthe probe. The exhaust gas
can freeze objects in close proximity. Therefore the
patient, skin, viscera and assistants should be protected
form exhaust tubing. The inlet and exhaust tubes are
supported by a hand-held gauze sling, to avoid contact
with the patient. We now use a polystyrene insulated
receptacle (beer cooler) attached to the exhaust tubing for
exhaust gas, to avoiddamaging theatre floors. The probes170 W.B. ROSS et al.
and exhaust tubing can be sterilized by autoclave, gas
sterilisation or by immersion. Probes are sterilised by
immersion for 10 minutes in gluteraldehyde solution. It is
important that the immersion liquid is excluded from the
insde of the probes and tubes by blanking off the tubes
with stoppers and running gas through the system prior to
using liquid nitrogen. Failure to do so will result in
immediate blockage by frozen liquid on contact with gas.
The line assemblies are sterilised in a similar manner; the
equipment is then rinsed with sterile water. Prior to the
first freeze, we test run the probes in a container of saline
to be sure that there is no leak of gas. A probe fracture
could clearly expose the patient to the risk of gas
embolism, although as soon as an ice ball is created, the
path ofleast resistance will be out ofthe exhaust channel.
We have not yet seen a probe failure in several thousand
freeze/thaw cycles in our animal and clinical experience.
.The joints in the system (probe/handle) should be
tightened to prevent leakage ofcoolant. During freezing
and thawing, the line assembly remains moderately pliable
but the silicon exhaust tubing is rigid when frozen and is
likely to fracture if moved. Two thermocouples are
included in the L.C.S. 2000 butwe also use a multi-channel
computer-based recording system. These may be useful
when monitoring the fringe of the iceball. However, we
routinely rely on intra-operative ultrasound to monitor the
size ofthe iceball (vide infra). After use, the equipment is
cleaned with warm, soapy water and sterilizing solution,
again ensuring that no liquid enters the apparatus.
The personnel required to operate the system safely
include: the surgeon and assistant, scrub nurse, and one
technician. The technician should be well trained in the
operation ofthe L.C.S. 2000 system and be able to connect
the various pipes during the procedure. Our technicians
are also responsible for the intraoperative ultrasound
machine and ultrasound dissagregator.
We have had no serious incidents or malfunction in
over 90 procedures in patients. The commonest technical
problemwe have had is leakage ofliquid nitrogen between
the line assembly and probe due to inadequate tightening
prior to freezing and, occasionally, leaks at the joint
between the L.C.S. 2000 machine and the line assembly
due to inadequate fixation or, on one occasion, a cracked
connector.
These include:-
i) Hypothermia
We have not noted a clear relationship between the
magnitude ofthe fall and duration ofsurgery or total
freeze time. In view of the risk of cardiovascular
complications such as conduction disturbances,
arryhthmias increases as the temperature drops, parti-
cularly ifhyperkalaemia develops.We routinely use a
warming device, and wrap the limbs with woolly
bandages and a spare blanket. If hypothermia is
becoming a problem, peritoneal lavage with hot saline
is used.
ii) Blood Loss
The quantity ranges from case to case. Mean blood
loss is 750 mls. More than 2000 mls is unusual.
Significant blood loss is usually associated with
’cracking’ofthe ice ball during thawing.
iii) Electrolyte Disturbances
There is a possibility of acute increase in potassium
from intra-cellular stores as cells lyse when thawing.
In association with hypothermia, this may be
arrhythmogenic.
iv) Thrombocytopaenia and Coagulopathy
Platelet consumption is ubiquitious in hepatic
cryotherapy. If extreme, this may contribute to a
bleeding diathesis. The platelet fall occurs for up to 2
days post-operatively. The exact magnitude of the
drop is unpredictable butmay in individual cases drop
to 25% ofpre-operative values. It is almost always self
limiting: we have only twice had to use platelet
transfusions and both of these patients required
re-operation.
v) Renal Dysfunction
Serious renal impairment is rare. Maintenance ofintra-
operative blood pressure, hydration, fluid resuscitation
and maintenance of urine output are important
measures in avoiding renal dysfunction. In our unit,
diuresis is not induced with diuretics or mannitol as a
AnaesthesiaforHepatic Cryotherapy
Anaestheticmanagement
Standard monitoring is applied to all patients. Other
monitors are used to detect the possible intra- and post-
operative sequelae ofhepatic cryotherapy (Table 3).
Table 3 Supplementary anaesthetic monitors for hepatic cryo-
therapy
Intra-arterial blood pressure
Central venous pressure
Oesophageal or nasopharyngeal temperature probe
Access to biochemical and haemtology labs
Any reasonable means ofmeasuring blood lossCRYOTHERAPYOF LIVERTUMOURS 171
routine but is used if intra-operative urine output is
inadequate or if any pinkish discolouration of the
urine is noted.
vi) Long Operation
Hepatic cryotherapy operations can frequently take
five hours. Calfcompressors, padding over pressure
areas and attention to positioning of the patients
should minimise venous stasis, pressure sores and
neuropraxias (Table 4).
hook on the transverse bar ofthe frame, while the sternum
is lifted strongly by the surgeon. The operating table is
tilted 20 head up. A second retractor can be used under
the right costal margin and attached to the lateral part of
the frame. The efficacy of this arrangement can be
improved by spreading the two chains with a rod or other
implement. Mobilization ofthe liver is important to allow
full assessment ofthe hepatic disease and to allow access
to the liver in the event ofmajor haemorrhage, especially
when treating large posterior tumours.
Drugs
Ifthere is no evidence ofhepatocellular dysfunction, then
drug pharmacokinetics appear not to be altered clinically,
although this has not been formally investigated during
hepatic cryotherapy. Itwould be prudent to avoid the use
Of halothane and avoid the risk of decreasing hepatic
blood flow and oxygen supply. Barbiturates, propofol,
benzodiazepines, opiates, non-depolarising muscle
relaxants have all been safely used.
Intra-operative Ultrasound
The extent ofliver malignancy is assessed using a suitable
intra-operative ultrasound system with sterilizable linear
array or mechanical sector probes8. The liver is examined
systematically, using the modern definitions ofsegmental
anatomy3. Tumour masses are identified and their
characteristics recorded: site, size, echoity (hyper/hypo-
echoic). The relationship oftumour to the major vascular
structures is noted.
Operative Technique
The patient is placed supine on the operating table.A right
subcostal incision is made, dividing the oblique muscles
and rectus abdominis. Many patients will have undergone
previous colonic resection for colorectal cancer there are
often adhesions to the midline wound. These adhesions
must be dissected to allow access to the liver, gall bladder
and hepatico-duodenal ligament. Secondly, it is important
to exclude the presence of extrahepatic disease such as
local recurrence or peritoneal spread, as this would be a
contraindication to treat the liver in most cases. When the
decision is made to proceed, the incisionmay be extended
by adding a left subcostal incision (rooftop) depending on
access, liver size and position ofmetastases. The lower flap
of abdominal wall is reflected back and sutured down.
Haemostasis of the incision and adhesion dissection
should be secured. The ligamentum teres is divided and
ligated. The falciform ligament is divided. Surgical access is
enhanced by elevating the lower end ofthe sternum using
a sternal lifting retractor 12. A rigid frame is placed
transversely above the patient’s neck, over which sterile
drapes are placed. The retractor is placed under the
xiphisternum and is attached by a chain to an adjustable
Table 4 Ancillary anaesthetic equipment for hepatic cryotherapy
2 medium bore (14G) IV cannulae
Calfcompressors
Warming mattress
Fluid warmers
Reflective blankets
Warmer Humidifer
Foam padding
ApplicationofCryoprobesAndCryotherapy
For small lesions on the surface ofthe liver, a trocar probe
may be applied directly without penetration ofthe tumour.
For larger lesions at the surface, a trocar probe is inserted
into the tumour under direct vision. For lesions deeply
placed within the liver substance which cannot be easily
palpated, a spinal needle is directed under ultrasound
guidance into the centre ofthe tumour. The cryotherapy
probe is inserted through the liver substance, using the
spinal needle as a guide both for angle and depth and
visualizing the process with the ultrasound. Multiple
attempts at tumour access must be avoided with the
relatively large cryoprobes. In addition, the track of the
probe is chosen to avoid damage to major vessels and
ducts. The inlet valve on the liquid nitrogen apparatus is
opened to maximum and freezing commences. At this
point, gauze swabs hold the inlet and outlet tubes away
from the patient’s body, protecting it from cold injury.
Cold gas from the exhaust should not come into contact
with any object which may be damaged by cold. Theatre
flooring can crack and at least one surgical assistant has
been injured by cold. The iceball growth can be monitored
using ultrasound. It appears very clearly as a dense black
image. Freezing continues until the iceball is seen to
exceed the tumour by a margin ofone centimetre. During
this time, the cryoprobe is supported to avoid mechanical
stress on the iceball caused by movement ofthe liver with
respiration. The average time taken to freeze a 5 cm
diameter lesion is 30 minutes. Freezing time may be
decreased by applying an atraumatic vascular clamp172 W.B. ROSS et al.
across the entire hepatic duodenal ligament. We use this
method for periods of up to one hour and use this
routinely for central, deep or large lesions. After achieving
complete freezing of the lesion, we allow the edge ofour
ice ball to thaw by approximately cm. In passive thawing
between double freeze/thaw sequence, no gas is used. We
do not allow lesions to completely thaw before re-freezing
as thiswould take a very long time but, more importantly,
is probably causally associated with the potentially fatal
cryoshock syndrome of renal, pulmonary and hepatic
failure with a haematological abnormality similar to
disseminated intravascular coagulation. The second
freeze should be allowed to go at least to the edge of the
first. We then pass treated nitrogen gas (unheated gas
works almost as rapidly) through the probe system allow
removal of the probe well before the iceball defrosts. Ice
balls are always allowed to completely thaw before closing
the abdomen: it is impossible to assess haemostasis unless
thawing is complete. The cryoprobe can be removed when
rotatory movement indicated that thawing has occurred
around the probe. Pre-cut fingers of oxidized celluose
foam are placed in the tract vacated by the probe4. Liver
sutures (chromic catgut) are used to control haemorrhage
from the thawed iceball in about 50% of cases. Major
bleeding can occur from these cracks and this can be
temporarily controlled by pressure or packing. The
surgeon using cryotherapy should have adequate training
to deal with themore severe forms ofthis iatrogenic liver
trauma. Ourmost difficult haemorrhage occurred in a soft
metastatic melanoma which literally fragmented; packs
were left in theabdomen and controlled this situation well.
At the end ofcryotherapy and thawing, a thorough check
is made for haemostasis. We routinely place a suction
drain above and below the liver.
HepaticIn-Flow Occlusion
For large lesions, the efficacy of cryotherapy can be
increased by occluding the hepatic inflow by placing a
vascular clamp across the hepaticoduodenal duodenal
ligament (Pringle’s maneoeuvre). We have shown that this
increases the zone of necrosis within the area of iceball
formationS4. Duration ofclamping should not exceed one
hour but itmay be re-applied after a recovery period of 15
minutes.
RegionalCytotoxicPerfusion
In all patients with colorectal cancer undergoing
cryotherapy, we place a subcutaneous reservior and
catheter to perfuse the liver. The gall bladder is removed to
prevent cytotoxic cholecystitis, the right gastric artery
ligated and divided and the superior aspect of the
duodenum devascularised. The gastroduodenal artery is
cannulated and the catheter tip fed in to sit at the origin
from the common hepatic artery. It is important to use a
catheter with a retaining ring so that ligatures will reliably
prevent its extrusion from the artery. We check perfusion
by injecting methylene blue. If unilateral perfusion is
achieved, we seek the anatomical abnormality and either
re-site the system or insert a second system. The catheter is
heparinised.
Post-OperativeManagement
Patients are usuallymanaged for the firstday ortwo on the
Surgical High Dependency Unit. Mechanical ventilation
may be required if the procedure was unduly long or the
patient significantly hypothermic. Routine monitoring of
pulse rate, blood pressure and temperature is performed.
Central venous pressure and hourly urine output are
measured. Pulse oximetry is routinely applied. Major
potential complications include early haemorrhage, renal
failure, pulmonary atelectasis, pleural effusion, subphrenic/
subhepatic collections and we have seen one hepatic
abscess following injection ofthe cryo-ablated lesion in a
patient who underwent synchronous colonic resection.
Most patients who have lesions near the diaphragm de-
velop pleural effusions-rarely, these have to be drained.
Peri-hepatic collections generally respond to percuta-
neous drainage by the radiologist. Respiratory physio-
therapy is appropriate for all patients. Routine early post-
operative investigation include full blood count, urea,
creatinine, electrolytes, liver function tests and coagula-
tion screen. Many patients have had previous colonic
resection and have extensive intra-peritoneal adhesions
which will have been dissected at the cryotherapy
operation. Prolonged paralytic ileus may therefore be
encountered. Post-operative pyrexia is common and a
cause is often not found the cryo-necrotised livermay well
be responsible. Imaging fails to demonstrate an abscess
collection. Routine culture ofurine, sputum, etc, although
necessary is unhelpful.
Follow-up
Therapeutic response is measured by monitoring tumour
markers. This is measured atmonthly intervals. Following
cryotherapy,CEA levels fall in almost allCEA secretors.A
subsequent rise inCEA level has always been predictive of
local or systemic relapse. Many of these patients are
investigated to assess the extent of the disease. In the
absence of extra-hepatic disease, further cryotherapy or
regional chemotherapymay be considered.CRYOTHERAPYOF LIVERTUMOURS 173
Addendum 1: Sterilization of cryoprobes: We are aware
of recent concern regarding the use of glutaldehyde
as a sterilizing agent. We now use ethylene oxide gas
sterilization.
Addendum 2: The LCS 2000 has been modified to recycle
liquid nitrogen. This is theLCS 3000.
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